MED RES REV 润色咨询

MEDICINAL RESEARCH REVIEWS

出版年份:1981 年文章数:656 投稿命中率: 开通期刊会员,数据随心看

出版周期:Bimonthly 自引率:0.5% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊简介

期刊简介
GetPortalImpactFactorByIdResp(projectId=1, id=17124760, cover=https://img.medsci.cn/images/journal/cover/2021/rur_202109271316020150.jpg, fullname=MEDICINAL RESEARCH REVIEWS, abbr=MED RES REV, pyear=1981, frequence=Bimonthly, articleNumbers=656, citedSelf2015=0.5, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=平均12.92月, reviewFee=null, pageFee=null, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=0198-6325, greenSci=https://www.greensci.net/search?kw=0198-6325, scijournal=https://www.scijournal.org/impact-factor-of-MED-RES-REV.shtml, medsciHotlightString=null, medsciHotlightRealtime=4.399, medsciHotlight=4.039, medsciHotlight5year=3.64671, citescore=17.2, hIndex=130, impactFactor=13.3, orgnization=John Wiley and Sons Inc., orgnizationUrl=http://onlinelibrary.wiley.com, country=United States, countryCn=美国, isOa=0, isOaString=否, sciScie=Science Citation Index|Science Citation Index Expanded|Current Contents - Life Sciences|BIOSIS Previews|BIOSIS Reviews Reports And Meetings, bigclassCas=医学 1区[Top], smallclassCas=, website=https://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1098-1128, websiteHits=7337, guideForAuthor=null, guideForAuthorHits=9, submitWebsite=https://mc.manuscriptcentral.com/med, submitWebsiteHits=1984, content=The journal publishes timely critical reviews of topics related to medicinal research broadly defined to which the authors have made significant contributions. Appropriate topics include but are not limited to the underlying pathophysiology of important diseases and disease vectors; therapeutic approaches to the treatment of various diseases; the properties of molecular targets for therapeutic agents; important new methodologies facilitating the search for therapies; genomics and proteomics; structure-activity correlations of drug series; the development of new imaging and diagnostic tools; drug metabolism; drug delivery; chemical pharmacological pharmacokinetic pharmacodynamic and clinical characteristics of importance. Reviews are mainly solicited by the editors; however voluntary contributions are also encouraged. In the latter case potential authors are asked to contact either co-editor with an outline before beginning to write in order to avoid duplication of effort and to ensure suitability of the topic and its level of coverage., totalCites=8727, brief=MED RES REV杂志医学行业,“<strong><a target="_blank" href="/sci/index.do?smallclass=药学" >药学</a></strong>”子行业的顶级杂志, articleType=本刊可能只接收综述类文章或很多文章不被WOS收录, medsciHeat=黑红, medsciComment=MED RES REV在该细分领域可能是一流杂志,可能是创刊时间短或不是热门学科,整体来说,国内学者关注度仍然不够。对于投稿而言,建议多向"&abbr&"投稿,当然期刊也应该加强品牌宣传。, medsciExplanation=MedSci期刊指数是根据中国科研工作者(含医学临床,基础,生物,化学等学科)对SCI杂志的认知度,熟悉程度,以及投稿的量等众多指标综合评定而成。当然,具体的,您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=17124760'>投稿经验系统</a>”,进行综合判断,这更是大家的实战经验,值得分享和参考。<br> 注意,上述MedSci期刊指数采用MedSci专利技术,由计算机系统自动计算,并给出建议,存在不准确的可能,仅供您投稿选择杂志时参考。, tags=[ImpactFactorTagDto(id=119, tagName=肿瘤, createdHits=1), ImpactFactorTagDto(id=10874, tagName=药理, createdHits=1), ImpactFactorTagDto(id=34724, tagName=心虚管, createdHits=1), ImpactFactorTagDto(id=266, tagName=心血管, createdHits=1), ImpactFactorTagDto(id=32736, tagName=极低出生体重儿, createdHits=1), ImpactFactorTagDto(id=114633, tagName=危重新生儿, createdHits=1), ImpactFactorTagDto(id=486527, tagName=新技术药物发现, createdHits=1)], citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2016, citescore=8.79), GetImpactFactorCiteScoreListResponse(year=2017, citescore=9.45), GetImpactFactorCiteScoreListResponse(year=2018, citescore=8.83), GetImpactFactorCiteScoreListResponse(year=2019, citescore=15.0), GetImpactFactorCiteScoreListResponse(year=2020, citescore=17.2)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=4.147), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=3.3), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=4.793), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=5.502), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=4.399)], citeScoreGradeList=[GetImpactFactorCiteScoreGradeResponse(smallClass=Pharmacology, Toxicology and Pharmaceutics - Drug Discovery , rank=3/146), GetImpactFactorCiteScoreGradeResponse(smallClass=Pharmacology, Toxicology and Pharmaceutics - Pharmacology , rank=7/300), GetImpactFactorCiteScoreGradeResponse(smallClass=Biochemistry, Genetics and Molecular Biology - Molecular Medicine , rank=5/165)], totalJcrAreaList=[GetImpactFactorCiteScoreGradeResponse(smallClass=CHEMISTRY, MEDICINAL, rank=Q1), GetImpactFactorCiteScoreGradeResponse(smallClass=PHARMACOLOGY & PHARMACY, rank=Q1)], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0198-6325[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=MEDICINAL RESEARCH REVIEWS[ta], article_number=63, article_number_cn=21, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)
期刊名称
MED RES REV/MEDICINAL RESEARCH REVIEWS
ISSN
0198-6325
影响指数话题
预警等级
MedSci期刊指数
4.399 (MedSci实时期刊指数) | 3.64671 (5年期刊指数)
CiteScore值
17.2
h-index
130
h5-median
暂无数据
出版社/管理机构
杂志由 John Wiley and Sons Inc. 出版或管理
出版国家/地区
United States 美国
出版周期
Bimonthly
出版年份
1981
是否OA
被收录情况
Science Citation Index|Science Citation Index Expanded|Current Contents - Life Sciences|BIOSIS Previews|BIOSIS Reviews Reports And Meetings
JCR分区
CHEMISTRY, MEDICINAL Q1
PHARMACOLOGY & PHARMACY Q1
中科院分区
大类:医学 1区[Top]
小类: